Scheme 1From: Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug deliverya Illustration of the preparation route to PLTM-CS-pPLGA/Bu NPs; b in vivo targeted bufalin delivery to a tumor site mediated by binding of P-selectin on the surface of the PLTM to CD44 receptors of the tumor cellsBack to article page